Patent details
300791
Product Name:
Isavuconazol als isavuconazonium sulfaat of als een isavuconazonium zout met elk ander farmaceutisch aanvaardbaar anion, naar keuze in de vorm van een farmaceutisch aanvaardbaar zout, hydraat of solvaat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300791
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1280795
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300791
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
Marketing Authorization Number:
EU/1/15/1036
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/10/2015
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
26/01/2016
First Marketing Authorization date:
19/10/2015
Grant date:
15/03/2016
Activation date:
25/10/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/02/2016
SPC/SPC Extension Expiration Date:
24/10/2025
Lapsed By Expiration Date:
25/10/2025
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
23/05/2023
Name:
Basilea Pharmaceutica International AG, Allschwil
Address:
Hegenheimermattweg 167b, 4123, Allschwil, Switzerland (CH)
Historical Applicant/holder
From:
26/01/2016
To:
23/05/2023
Name:
Basilea Pharmaceutica International Ltd.
Address:
Grenzacherstrasse 487, 4058, BASEL, Switzerland (CH)
Agent
Name:
ir. J.C. Volmer c.s.
From:
10/02/2016
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
44/25
Publication date:
29/10/2025
Description:
Lapse or annulment
2
Bulletin Heading:
CO
Journal edition number:
23/23
Publication date:
07/06/2023
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
44/20
Publication date:
28/10/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
11/16
Publication date:
16/03/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
SPC
Journal edition number:
07/16
Publication date:
17/02/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202301034A
Date Registered:
23/05/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Basilea Pharmaceutica International AG, Allschwil
Address:
Hegenheimermattweg 167b, 4123, Allschwil, Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Other
Note:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
06/09/2024
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Patrix IP Services
Filing date
Document type
Document Description
Number of pages
File Type
15/03/2016
SPC Documents
Certificate SPC
1
PDF
/2/8/5/0/3/0800030582/docs/300791_7_supplprotectioncertificate20201215031008368.pdf
15/03/2016
Outgoing Correspondence
Decision grant
2
PDF
/2/8/5/0/3/0800030582/docs/300791_10_outgoingcorrespondence20201215031008281.pdf
12/02/2016
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/8/5/0/3/0800030582/docs/300791_3_outgoingcorrespondence20201215030712137.pdf
26/01/2016
Payment Order Dossier
Payment Order
1
PDF
/2/8/5/0/3/0800030582/docs/300791_0_paymentorderdossier20160210020705418.pdf
26/01/2016
Application Form
First filed application form
2
PDF
/2/8/5/0/3/0800030582/docs/300791_1_applicationform20160210020705362.pdf
26/01/2016
SPC Documents
Annex SPC
22
PDF
/2/8/5/0/3/0800030582/docs/300791_2_supplprotectioncertificate20201215025742121.pdf
26/01/2016
SPC Documents
Annex SPC
41
PDF
/2/8/5/0/3/0800030582/docs/300791_4_supplprotectioncertificate20201215025741974.pdf
26/01/2016
SPC Documents
Annex SPC
1
PDF
/2/8/5/0/3/0800030582/docs/300791_5_supplprotectioncertificate20201215023216274.pdf
26/01/2016
SPC Documents
Annex SPC
6
PDF
/2/8/5/0/3/0800030582/docs/300791_6_supplprotectioncertificate20201215030354850.pdf
26/01/2016
SPC Documents
Accompanying letter SPC
2
PDF
/2/8/5/0/3/0800030582/docs/300791_8_supplprotectioncertificate20201215030548034.pdf
26/01/2016
SPC Documents
Annex SPC
22
PDF
/2/8/5/0/3/0800030582/docs/300791_9_supplprotectioncertificate20201215022801194.pdf
26/01/2016
SPC Documents
Marketing Authorization SPC
5
PDF
/2/8/5/0/3/0800030582/docs/300791_11_supplprotectioncertificate20201215025741874.pdf
26/01/2016
SPC Documents
Annex SPC
2
PDF
/2/8/5/0/3/0800030582/docs/300791_12_supplprotectioncertificate20201215025742046.pdf
26/01/2016
SPC Documents
Annex SPC
2
PDF
/2/8/5/0/3/0800030582/docs/300791_13_supplprotectioncertificate20201215022801136.pdf
26/01/2016
SPC Documents
Summary of the characteristics of the product
42
PDF
/2/8/5/0/3/0800030582/docs/300791_14_supplprotectioncertificate20201215022801048.pdf